top of page

3/1/2022 Journal Club

Our first ever journal club was a success and covered some incredible and, at times, controversial topics! The event was recorded can be viewed at the lin

k below. We hope to see you at the next Journal Club!

1. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

Christopher T. Aquina, MD, MPH

Colon & Rectal Surgery Fellow

AdventHealth – Orlando

(Mentor- Dr. Mark Soliman)

2. Achieving a Complete Clinical Response After Neoadjuvant Chemoradiation That Does Not Require Surgical Resection: It May Take Longer Than You Think!

Ashwini Paranjpe, MD General Surgery Resident, PGY 4

University of Miami, JFK Medical Center

(Mentor- Dr. Juliet Ray)

3. Closure of Temporary Ileostomy 2 Versus 12 Weeks After Rectal Resection for Cancer: A Word of Caution From a Prospective, Randomized Controlled Multicenter Trial

Karina Cardenas, MD

General Surgery Resident, PGY 2

Westside Regional Medical Center

(Mentor- Dr. Joe Corallo)

4. What Is the Optimal Elective Colectomy for Splenic Flexure Cancer: End of the Debate? A Multicenter

Study From the GRECCAR Group With a Propensity Score Analysis

Andrew Morgan, MD

Colon & Rectal Surgery Fellow

Cleveland Clinic Florida

(Mentor- Dr. Eric Weiss)

Visit us on Instagram/Twitter at @flscrs or on our website for more info:

Passcode: N?uYSM6w
11 views0 comments


bottom of page